2019

US Patent granted for all neuro-muscular conditions

FDA filing for JOGO - Gx

Launch clinical trials  for three conditions

2020

JOGO-Gx FDA 510(K) Exemption Received, April 2020

Post stroke plantar flexor spasticity and ankle dorsiflexion recovery

Chronic lower back pain

Post COVID-19 Myalgic Encephalomyelitis / Chronic Fatigue Syndrome

2021

Migraine and Tension Headache

Fibromyalgia

Urinary Incontinence

Constipation

2022

Migraine

Needle-less EMG Nerve Conduction Testing

Fecal Incontinence

Premature Ejaculation

2025

Cerebral Palsy, Sleep bruxism, Patellofemoral pain syndrome, Swallowing disorder (dysphagia)  Pain relief in cancer patients , temporomandibular disorders ,vulvar vestibulitis, subacromial impingement syndrome